Carbimazole embryopathy: Implications for the choice of antithyroid drugs in pregnancy

QJM: An International Journal of Medicine

Volumn 105, Issue 2, 2012, Pages 189-193

  Bowman, P ^a   Osborne, N J ^a   Sturley, R ^a   Vaidya, B ^a  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM; CARBIMAZOLE; LIOTRIX; THYROTROPIN; THYROXINE;

ARTICLE; BIRTH WEIGHT; BLOOD ANALYSIS; CASE REPORT; CHOANA ATRESIA; CONGENITAL MALFORMATION; DRUG DOSE REDUCTION; ENDOSCOPY; ESOPHAGUS ATRESIA; FEMALE; FORCEPS DELIVERY; GRAVES DISEASE; HUMAN; INFANT; LARYNGOMALACIA; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; SKIN APLASIA;

EID: 84856121193     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq248     Document Type: Article

References (23)

1. Milham S Jr, Elledge W. Maternal methimazole and congenital defects in children. Teratology 1972; 5:125-6.
2. Van Dijke CP, Haydendael RJ, De Klein MJ. Methimazole, carbimazole and congenital skin defects. Ann Intern Med 1987; 106:60-1.
3. Singh S, Pandey A, Ahmed I, Rawat JD, Sharma A, Srivastava NK. Prolapse of bowel via patent vitello intestinal ducta rare occurrence. Hernia 2010 [Epub ahead of print; 17th June 2010; doi 10.1007/s10029-010-0689-5].
4. Milham S Jr. Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy. Teratology 1985; 32:321.
5. Foulds N, Walpole I, Elmslie F, Mansour S. Carbimazole embryopathy: an emerging phenotype. Am J Med Genet 2005; 132A:130-5.
6. Kannan L, Mishra S, Agarwal R, Kartikeyan V, Gupta N, Kabra M. Carbimazole embryopathy - bilateral choanal atresia and patent vitello-intestinal duct: a case report and review of literature. Birth Defects Res A Clin Mol Teratol 2008; 82:649-51.
7. Wilson LC, Kerr BA, Wilkinson R, Fossard C, Donnai D. Choanal atresia and hypothelia following methimazole exposure in utero: a second report. Am J Med Genet 1998; 75:220-2.
8. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 1999; 83:43-6.
9. Ferraris S, Valenzise M, Lerone M, Divizia MT, Rosaia L, Blaid D, et al. Malformations following methimazole exposure in utero: an open issue. Birth Defects Res A Clin Mol Teratol 2003; 67:989-92.
10. Greenberg F. Choanal atresia and athelia: methimazole teratogenicity or a new syndrome? Am J Med Genet 1987; 28:931-4.
11. Wolf D, Foulds N, Daya H. Antenatal carbimazole and choanal atresia. A new embryopathy. Arch Otolaryngol Head Neck Surg 2006; 132:1009-11.
12. Myers AK, Reardon W. Choanal atresia - a recurrent feature of foetal carbimazole syndrome. Clin Otolaryngol 2005; 30:364-83.
13. Hall BD. Methimazole as a teratogenic aetiology of choanal atresia/multiple congenital anomaly syndrome. Am J Hum Genet 1997; 61:A100.
14. Barwell J, Fox G, Round J, Berg J. Choanal atresia: the result of maternal thyrotoxicosis or fetal carbimazole? Am J Med Genet 2002; 111:55-6.
15. Rosenfeld H, Omoy A, Schechtman S, Diav-Citrin O. Pregnancy outcome, thyroid dysfunction, and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharm 2009; 68:609-17.
16. Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynaecol 1994; 170:90-5.
17. Karlsson FA, Axelsson O, Melhus H. Severe embryopathy and exposure to methimazole in early preganancy. J Clin Endocrinol Metab 2002; 87:947-8.
18. Clementi M, Di Gianantonio, Cassina M, Leoncini E, Botto L, Mastroiacovo P; SAFE-Med study group. Treatment of Hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab 2010; 95:E337-E341.
19. Barbero P, Valdez R, Rodriguez H, Tiscornia C, Mansilla E, Allons A, et al. Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A 2008; 146A:2390-5.
20. Seoud M, Nassar A, Usta I, Mansour M, Salti I, Younes K. Gastrointestinal malformations in two infants born to women with hyperthyroidism untreated in the first trimester. Am J Perinatol 2003; 20:59-62.
21. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Gilinoer D, et al. Management of thyroid dysfunctionduring pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007; 92(Suppl. 8):S1-47
22. Cooper DS, Rivkees SA. Putting propylthiouracil in perspective. J Clin Endocrinol Metab 2009; 94:1881-2.
23. US Food and Drug Administration. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm162701.htm (Accessed 1st November 2010).